Citation: | ZHANG Zhen-huan, WANG Dan-na, WU Shi-wu. Expressions of CD133 and extracellular signal-regulated protein kinase 1 in papillary thyroid carcinoma and their correlations[J]. Journal of Bengbu Medical University, 2014, 39(8): 1005-1007,1011. |
[1] |
Volante M, Papotti M.Poorly differentiated thyroid carcinoma:5 years after the 2004 WHO classification of endocrine tumours[J].Endocr Pathol, 2010, 21(1):1-6.
|
[2] |
Menakongka A, Suthiphongchai T.Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion[J].World J Gastroenterol, 2010, 16(6):713-722.
|
[3] |
Bhola NE, Balko JM, Dugger TC, et al.TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer[J].J Clin Invest, 2013, 123(3):1348-1358.
|
[4] |
Chiba T, Kamiya A, Yokosuka O, et al.Cancer stem cells in hepatocellular carcinoma:Recent progress and perspective[J].Cancer Lett, 2009, 286(2):145-153.
|
[5] |
陆国玉, 吴晓飞, 周蕾, 等.CD133和CD44在胃腺癌中的表达及其与E-cadherin的关系[J].南方医科大学学报, 2013, 33(11):1632-1637.
|
[6] |
武世伍, 承泽农, 俞岚, 等.CD82/KAI1和HIF-1α在非小细胞肺癌中的表达及其与血管生成拟态的关系[J].中国肺癌杂志, 2011, 14(12):918-925.
|
[7] |
Wakamatsu Y, Sakamoto N, Oo HZ, et al.Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer[J].Pathol Int, 2012, 62(2):112-119.
|
[8] |
Xu YH, Zhang GB, Wang JM, et al.B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis[J].Saudi Med J, 2010, 31(9):980-986.
|
[9] |
Schneider M, Huber J, Hadaschik B, et al.Characterization of colon cancer cells:a functional approach characterizing CD133 as a potential stem cell marker[J].BMC Cancer, 2012, 12:96.
|
[10] |
Hamon B, Hamon P, Bovier-Lapierre M, et al.A child with resistance to thyroid hormone without thyroid hormone receptor gene mutation:a 20-year follow up[J].Thyroid, 2008, 18(1):35-44.
|
[11] |
夏文戎, 付文亮, 蔡玲, 等.血管生成素通过ERK信号通路促进HeLa细胞的增殖[J].军事医学, 2013, 37(1):53-57.
|
[12] |
De Luca A, Maiello MR, D'Alessio A, et al.The RAS/RAF/MEK/ERK and the PI3K/AKT signaling pathways:role in cancer pathogenesis and implications for therapeutic approaches[J].Expert Opin Ther Targets, 2012(16 Suppl 2):S17-S27.
|
[13] |
Chakraborti S, Mandal M, Das S, et al.Regulation of matrix metallo-proteinases:a overview[J].Mol Cell Biochem, 2003, 253(1/2):269-235.
|